Velarion · Company Intelligence
CompBrief
Fiscal year 2024

Adrian Rawcliffe — FY2024 total compensation $2,109,075

Adrian Rawcliffe is Chief Executive Officer and Director of Adaptimmune Therapeutics PLC (ADAP). The company reported total compensation of $2,109,075 for fiscal year 2024.

01

Fiscal year 2024 compensation

Salary$676,000
Bonus$0
Stock awards$0
Option awards$1,065,820
Non-equity incentive plan$324,480
Pension and non-qualified deferred compensation$0
All other compensation$42,775
Total$2,109,075

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.

Cited to the compensation disclosure Adaptimmune Therapeutics PLC filed April 25, 2025, accession 0001104659-25-039042.

02

History — every fiscal year held

Fiscal yearRoleSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
FY2024Chief Executive Officer and Director$676,000$0$0$1,065,820$324,480$0$42,775$2,109,075
FY2023Chief Executive Officer and Director$650,000$0$0$1,716,163$370,500$0$37,378$2,774,041

Totals as disclosed in each year's own compensation disclosure for Adaptimmune Therapeutics PLC.

03

Peer context

Peer-group chief executive median$2,978,038
Difference from that median$-868,963
Percentile within the disclosed peer group20th
Peers with a disclosed figure15

Medians and percentiles are computed across the peer group Adaptimmune Therapeutics PLC discloses in its own compensation disclosure.

04

The other named executive officers of Adaptimmune Therapeutics PLC

Named executive officerRoleFY2024 total
Adrian Rawcliffe this pageChief Executive Officer and Director$2,109,075
Cintia PiccinaChief Commercial Officer$1,746,296
William BertrandChief Operating Officer$1,058,369

The company's named executive officers for fiscal year 2024, and what it reported for each. See the full Adaptimmune Therapeutics PLC compensation brief.

05

The company page

Adrian Rawcliffe's compensation sits inside Adaptimmune Therapeutics PLC's full executive and board picture — the peer group, pay against peers, incentive design and the board itself.

The Adaptimmune Therapeutics PLC (ADAP) compensation brief